gendicine

tumor protein p53 ; Homo sapiens







8 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32951572 Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China. 2020 2
2 29338444 The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic. 2018 Feb 1
3 27843742 Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis. 2016 1
4 24457472 Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma. 2014 Feb 2
5 19882171 Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma. 2010 Apr 1
6 20679889 p53 gene therapy for pulmonary metastasis tumor from hepatocellular carcinoma. 2010 Oct 1
7 19318914 A patient with huge hepatocellular carcinoma who had a complete clinical response to p53 gene combined with chemotherapy and transcatheter arterial chemoembolization. 2009 Jun 1
8 16188130 [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma]. 2005 Jul 2